跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge - TGA Drug Approval Details
Approvals
/
TGA
/
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge
Approved
STANDARD
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge
Eli Lilly Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2f65083d4f13dcc2
Company
Eli Lilly Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2f65083d4f13dcc2
Product Name
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge
Artg Id
215551
Artg Name
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge
Sponsor
Eli Lilly Australia Pty Ltd
Company Detail Path
/organization/eli-lilly-australia-pty-ltd
Artg Date
2014-11-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2f65083d4f13dcc2
Type
Standard
Back to TGA Approvals
